Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00581217 · ClinicalTrials.gov registry record
A Randomized Comparison Study of Aquacel Ag and Glucan II as Donor Site Dressings
A clinical trial, sponsored by University of California, Irvine.
- Terminated
- Registry status
- 20
- Enrollment target
NCT00581217: Clinical Trial study, sponsored by University of California, Irvine.
NCT00581217 is a clinical trial that was terminated before completion, run by University of California, Irvine. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00581217 was terminated before completion, sponsored by University of California, Irvine.
- TERMINATED
- Registry status
- 20 participants
- Enrollment target
Study Summary
The research will be looking at patient outcomes for healing of donor sites after a split-thickness skin graft procedure for a burn or skin tissue loss. Donor site healing time, infection rate, cosmetic outcome, and patient's rating of pain will be compared between two donor site dressings, Glucan II and Aquacel Ag.
Interventions
- OTHER Aquacel Ag
- OTHER Glucan II
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2007-12 |
| Est. Completion | 2010-09 |
Why NCT00581217 stopped before completion
NCT00581217 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Aquacel Ag is the first listed.
NCT00581217 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00581217 about?
NCT00581217 is a clinical study titled "A Randomized Comparison Study of Aquacel Ag and Glucan II as Donor Site Dressings". The research will be looking at patient outcomes for healing of donor sites after a split-thickness skin graft procedure for a burn or skin tissue loss. Donor site healing time, infection rate, cosmetic outcome, and patient's rating of pain will be compared between two donor site dressings, Glucan I...
What is the current status of trial NCT00581217?
This trial is currently terminated. The enrollment target is 20 participants. The study started on 2007-12. Estimated completion is 2010-09.
What interventions are being tested in trial NCT00581217?
The interventions under investigation include: Aquacel Ag (OTHER), Glucan II (OTHER).
Who is sponsoring clinical trial NCT00581217?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia